Atea Pharmaceuticals Ownership | Who Owns Atea Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Atea Pharmaceuticals Ownership Summary


Atea Pharmaceuticals is owned by 62.97% institutional investors, 12.92% insiders, and 24.11% retail investors. Blackrock is the largest institutional shareholder, holding 10.87% of AVIR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.87% of its assets in Atea Pharmaceuticals shares.

AVIR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtea Pharmaceuticals62.97%12.92%24.11%
SectorHealthcare Stocks 41.89%10.80%47.31%
IndustryBiotech Stocks 43.99%10.76%45.25%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock9.12M10.87%$30.19M
Blackrock funding, inc. /de8.46M10.10%$24.53M
Bml capital management7.47M8.92%$21.67M
Fmr5.82M6.95%$16.89M
Tang capital management4.83M5.76%$14.00M
Vanguard group4.71M5.62%$13.66M
Bain capital life sciences investors2.49M2.97%$7.21M
Geode capital management1.90M2.27%$5.51M
State street1.78M2.13%$5.17M
Dimensional fund advisors lp1.54M1.84%$4.47M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management7.47M19.85%$21.67M
Cm management500.00K1.21%$1.45B
Peapod lane capital457.22K1.19%$1.33M
Tang capital management4.83M0.54%$14.00M
Bain capital life sciences investors2.49M0.48%$7.21M
Rangeley capital80.00K0.20%$232.00K
Newtyn management492.28K0.17%$1.43M
Auour investments177.00K0.17%$513.30K
Eversource wealth advisors150.88K0.02%$437.55K
Sunpointe11.94K0.01%$34.63K

Top Buyers

HolderShares% AssetsChange
Royal bank of canada301.88K0.00%289.65K
Group one trading144.19K0.00%139.95K
Dimensional fund advisors lp1.54M0.00%129.45K
Jane street group192.09K0.00%121.70K
Two sigma investments, lp471.29K0.00%104.68K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---3.34M
Almitas capital---445.39K
Acuitas investments---323.54K
Blackrock funding, inc. /de8.46M0.00%-209.31K
Vanguard group4.71M0.00%-177.95K

New Positions

HolderShares% AssetsChangeValue
Cubist systematic strategies87.77K0.00%87.77K$254.54K
Certified advisory24.50K0.01%24.50K$71.05M
Millennium management22.51K-22.51K$75.39K
Hrt financial lp18.84K0.00%18.84K$54.00K
Jump financial14.01K0.00%14.01K$40.62K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-15.00
Federation des caisses desjardins du quebec-24.00
Capital performance advisors llp-31.00
Smartleaf asset management-46.00
Colonial trust advisors-46.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20251137.62%52,737,5330.09%621.59%41-16.33%4053.85%
Jun 30, 2025104-52,674,2040.85%621.67%4911.36%25-32.43%
Mar 31, 2025104-2.80%52,838,521-6.02%621.40%45-15.09%3822.58%
Dec 31, 2024105-2.78%56,185,130-2.97%661.41%52-1.89%303.45%
Sep 30, 20241081.89%57,907,5112.15%681.50%5414.89%28-24.32%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S3.86M4.87%1.74K
Fidelity Growth Compy Commingled Pl O3.73M4.42%23.40K
Vanguard Total Stock Mkt Idx Inv2.38M2.93%-52.37K
Vanguard US Total Market Shares ETF2.36M2.76%-
iShares Russell 2000 ETF1.79M2.26%-
Fidelity Growth Company Fund938.18K1.18%-5.62K
Vanguard Institutional Extnd Mkt Idx Tr885.85K1.09%-427.22K
Fidelity Small Cap Index756.17K0.93%-16.78K
Fidelity Growth Company K6671.24K0.85%-3.62K
iShares Russell 2000 Value ETF663.05K0.84%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 16, 2025BERGER FRANKLIN M-Buy$33.61K
Jan 15, 2025BERGER FRANKLIN M-Buy$47.88K
Jan 16, 2025BERGER FRANKLIN M-Sell$33.61K
Jan 15, 2025BERGER FRANKLIN M-Sell$47.88K
Dec 10, 2024BERGER FRANKLIN M-Sell$1.02M

Insider Transactions Trends


DateBuySell
2025 Q14-
2024 Q4-1
2024 Q3-3
2024 Q2-2
2024 Q1-6

AVIR Ownership FAQ


Who Owns Atea Pharmaceuticals?

Atea Pharmaceuticals shareholders are primarily institutional investors at 62.97%, followed by 12.92% insiders and 24.11% retail investors. The average institutional ownership in Atea Pharmaceuticals's industry, Biotech Stocks , is 43.99%, which Atea Pharmaceuticals exceeds.

Who owns the most shares of Atea Pharmaceuticals?

Atea Pharmaceuticals’s largest shareholders are Blackrock (9.12M shares, 10.87%), Blackrock funding, inc. /de (8.46M shares, 10.10%), and Bml capital management (7.47M shares, 8.92%). Together, they hold 29.89% of Atea Pharmaceuticals’s total shares outstanding.

Does Blackrock own Atea Pharmaceuticals?

Yes, BlackRock owns 10.87% of Atea Pharmaceuticals, totaling 9.12M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.19M$. In the last quarter, BlackRock decreased its holdings by -123K shares, a -1.33% change.

Who is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 19.85% of its assets in 7.47M Atea Pharmaceuticals shares, valued at 21.67M$.

Who is the top mutual fund holder of Atea Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Atea Pharmaceuticals shares, with 4.87% of its total shares outstanding invested in 3.86M Atea Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools